SUMMIT THERAPEUTICS
Live / Registered — Registered (as of 10 Mar 2026)
What this means for you
Registered since 10 Mar 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98977458
- Registration number
- 8171341
- Mark type
- Stylized text
- Filed
- 08 Apr 2024
- Published for opposition
- 07 Jan 2025
- Registered
- 10 Mar 2026
- Attorney of record
- Andrea M. Porterfield
Goods and services
- Class 042 — Scientific and technological services: Drug discovery services for the identification and analysis of therapeutics for use in oncology and immuno-oncology; Research and development services in the field of therapeutics for the treatment of cancer; Research and development services in the fields of oncology and immuno-oncology; Providing medical and scientific research information in the field of biopharmaceuticals; Providing medical and scientific research information in the field of cancer
- Class 044 — Medical, beauty and agricultural services: Healthcare services, namely, providing patient treatment services in the fields of oncology and immuno-oncology; Provision of medical services in the field of oncology and immuno-oncology for the treatment of patients; Advice relating to oncology and immuno-oncology; Providing medical care services in the field of oncology and immuno-oncology; Providing medical information in the field of cancer; Medical counseling in the field of oncology and immuno-oncology; Clinical medical consulting in the field of oncology and immuno-oncology
Owner
- SUMMIT THERAPEUTICS SUB INC., Menlo Park, CA, US
- SUMMIT THERAPEUTICS SUB INC., Menlo Park, CA, US
- SUMMIT THERAPEUTICS SUB INC., Menlo Park, CA, US
Prosecution history
- 10 Mar 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 10 Mar 2026 — REGISTERED-PRINCIPAL REGISTER
- 13 Feb 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 13 Feb 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 12 Feb 2026 — ASSIGNED TO EXAMINER
- 26 Jan 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 08 May 2025 — USE AMENDMENT FILED
- 26 Jan 2026 — DIVISIONAL PROCESSING COMPLETE
- 07 May 2025 — DIVISIONAL REQUEST RECEIVED
- 16 Jan 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 07 May 2025 — TEAS REQUEST TO DIVIDE RECEIVED
- 07 May 2025 — TEAS STATEMENT OF USE RECEIVED
- 04 Mar 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 07 Jan 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Jan 2025 — PUBLISHED FOR OPPOSITION